Adocia Investor Relations Material
Latest events
Access the full event backlog
Slides, Transcripts, and Reports from 9,000+ public companies
Latest reports from Adocia SA
Access all reports
Adocia SA is a biotechnology company focused on the development of innovative therapies for the treatment of diabetes and other metabolic diseases. The company specializes in creating advanced formulations of already approved therapeutic proteins, aiming to improve their efficacy and patient experience. Adocia's technology platforms are designed to optimize the delivery and performance of these treatments, particularly in the field of insulin therapy. The company is headquartered in Lyon, France, and its shares are listed on the Euronext Paris exchange.
Key slides for Adocia SA
Investor Presentation
Adocia SA
Investor Presentation
Adocia SA
Latest articles
The Art of Portfolio Management: Lessons from Tom O'Hara
Tom O'Hara shares insights on stock picking, navigating market distractions, and the importance of one-on-one meetings with management teams.
4 Oct 2024
The Samsung Co-CEOs: Jong-Hee Han & Young-Hyun Jun
Samsung Electronics' dual-CEO structure, led by Jong-Hee Han and Young-Hyun Jun, is designed to navigate the complexities of its diverse business.
3 Oct 2024
Irwin Jacobs & Andrew Viterbi: Qualcomm's Pioneering Founders
In 1985, Irwin Jacobs and Andrew Viterbi co-founded Qualcomm, a leading company in telecommunications and semiconductor innovation.
3 Oct 2024
Ticker symbol
ADOC
Country
🇫🇷 France